
Singapore · Food production startup
Umami Bioworks is a biotech company based in Singapore, founded in 2020.
Funding reportedLast round: Convertible note
Umami Bioworks is a biotech company based in Singapore, founded in 2020.
The company focuses on developing delicious, affordable, and sustainable cultivated seafood, specifically cultivated fish. Their mission is to create nutritious seafood that supports human health and ocean sustainability. The company operates a proprietary TechBio platform that utilizes advanced technologies, including machine learning, multi-omics biomarkers, and digital twins, to enhance the production of cultivated seafood. Umami Bioworks provides biomanufacturing services and partners with market leaders in various industries, including human food, cosmetics, and pet nutrition, to promote sustainable blue bioeconomy solutions. With a small team of around 12 employees, the company is rapidly growing and also has an R&D center in India.
Funding, as reported
From Umami Bioworks's own website: 5 on the team.
AdvisersShahrukh Marfatia
What they build
Known for
species-specific cell linesconsumersscalable productionreduction of ocean pollutantsmanufacturingcell culture technology3d-printed fish filletsai-driven developmentinformation technology & servicespet nutritioncosmeticsfood productionautomated bioprocessingenvironmental servicescultivated seafoodbiomanufacturing
Built with from their website
WordPress.orgApacheGoogle WorkspaceViewport MetaAIGoogle MeetReactCAPTCHAGoogle Font APIBigCommerce
MySQLMobile FriendlyScene7BootstrapOpen GraphRuby On RailsjQueryRuby
Add your raise, your deck and your story, and put Umami Bioworks in front of investors. Or tell us what we have wrong.